Hyder A. Jinnah (United States of America)

Emory University School of Medicine Neurology & Human Genetics
H. A. (Buz) Jinnah is at Emory University in Atlanta where he is Professor of Neurology, Human Genetics, and Pediatrics. He has a clinical practice and research program devoted to all types dystonia, with a special interest in neurogenetic disorders. He currently is Director of the Dystonia Coalition, an initiative funded by the NIH to stimulate clinical and translational research in dystonia, with more than 40 collaborating institutions from several countries across North America, Europe, and Asia. He has given over 100 invited lectures internationally. He has published more than 200 articles addressing a variety of topics including genetics and biochemistry, cell biology, anatomy and histopathology, and clinical and translational studies. His neurosciences laboratory currently is focused on induced pluripotent stem cell models and animal models of dystonia including Lesch-Nyhan disease, dopa-responsive dystonia, DYT1 dystonia and others. His clinical research currently is focused on clinical trials and translational studies needed to bring new treatments to patients.

Author Of 2 Presentations

 Conference Calendar
TC Workshops

BOTULINUM TOXIN FOR MOVEMENT DISORDERS. A CASE-BASED APPROACH FOR CHALLENGING DISORDERS

Session Type
TC Workshops
Session Name
2100 - BOTULINUM TOXIN WORKSHOP (ID 101)
Date
05.10.2021, Tuesday
Session Time
11:00 - 13:00
Room
Workshop
Lecture Time
11:40 - 12:00
Presenter
  • Hyder A. Jinnah (United States of America)
Scientific Session: MT (Main Topics)

RARE BUT TREATABLE INHERITED MOVEMENT DISORDERS

Session Type
Scientific Session: MT (Main Topics)
Session Name
1100 - MOVEMENT DISORDERS - RARE AND TREATABLE MOVEMENT DISORDERS (WFN/INTERNATIONAL PARKINSON AND MOVEMENT DISORDER JOINT SESSION) (ID 93)
Date
05.10.2021, Tuesday
Session Time
17:10 - 18:40
Room
Main Topic B
Lecture Time
17:56 - 18:19
Presenter
  • Hyder A. Jinnah (United States of America)

Abstract

Abstract Body

There are more than 6000 rare human disorders, and half of them have neurological symptoms and signs. For many of these disorders, symptom-targeted treatments may be at least partly beneficial. For a few of these disorders, there are more special treatments. These special treatments often have a major impact on the symptoms of the disorder, or they may prevent progression of the disorder. Most of these disorders begin in childhood, but some do not come to medical attention until adulthood. One of the best examples is Wilson’s disease. If treatments are started early enough, they can reverse symptoms and stop the neurodegenerative process. If the diagnosis is delayed and treatment starts late, neurodegeneration can be stopped, but symptoms from existing brain damage may not imprve. Wilson’s disease is not unique. There are numerous other rare movement disorders with special treatments. These special treatments include detoxification strategies that reduce accumulation of a harmful substance, replacement strategies that restore some missing ingredient, recognition and avoidance of specific triggers, and dietary interventions. Although the disorders associated with special treatments are rare, they should not be missed, because early treatment is essential.

Hide

Presenter of 2 Presentations

 Conference Calendar
TC Workshops

BOTULINUM TOXIN FOR MOVEMENT DISORDERS. A CASE-BASED APPROACH FOR CHALLENGING DISORDERS

Session Type
TC Workshops
Session Name
2100 - BOTULINUM TOXIN WORKSHOP (ID 101)
Date
05.10.2021, Tuesday
Session Time
11:00 - 13:00
Room
Workshop
Lecture Time
11:40 - 12:00
Presenter
  • Hyder A. Jinnah (United States of America)
Scientific Session: MT (Main Topics)

RARE BUT TREATABLE INHERITED MOVEMENT DISORDERS

Session Type
Scientific Session: MT (Main Topics)
Session Name
1100 - MOVEMENT DISORDERS - RARE AND TREATABLE MOVEMENT DISORDERS (WFN/INTERNATIONAL PARKINSON AND MOVEMENT DISORDER JOINT SESSION) (ID 93)
Date
05.10.2021, Tuesday
Session Time
17:10 - 18:40
Room
Main Topic B
Lecture Time
17:56 - 18:19
Presenter
  • Hyder A. Jinnah (United States of America)

Abstract

Abstract Body

There are more than 6000 rare human disorders, and half of them have neurological symptoms and signs. For many of these disorders, symptom-targeted treatments may be at least partly beneficial. For a few of these disorders, there are more special treatments. These special treatments often have a major impact on the symptoms of the disorder, or they may prevent progression of the disorder. Most of these disorders begin in childhood, but some do not come to medical attention until adulthood. One of the best examples is Wilson’s disease. If treatments are started early enough, they can reverse symptoms and stop the neurodegenerative process. If the diagnosis is delayed and treatment starts late, neurodegeneration can be stopped, but symptoms from existing brain damage may not imprve. Wilson’s disease is not unique. There are numerous other rare movement disorders with special treatments. These special treatments include detoxification strategies that reduce accumulation of a harmful substance, replacement strategies that restore some missing ingredient, recognition and avoidance of specific triggers, and dietary interventions. Although the disorders associated with special treatments are rare, they should not be missed, because early treatment is essential.

Hide